Levadex Receives Complete Response Letter, What Does This Mean for the Stock? (MAPP, $16.44)Sunday, April 8, 2012 · 1:22 pm |
|
Levadex Has a Good Chance for Approval on its March 26th PDUFA Date (MAPP, $17.09)Sunday, April 8, 2012 · 1:10 pm |
|
Initiating Coverage of MAP Pharmaceuticals with A Buy Based On Potential for Levadex (MAPP, $13.35)Thursday, December 15, 2011 · 10:53 am |
|
There are 3 reports on file. |